Katharina Lueckerath

Has grant

Professor

University Hospital Essen

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Medical Imaging Medical Imaging professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Towards a curative RLT dose in prostate cancer through dosimetry optimization, combination therapies, and stroma targeting

Open Date: 2019-10-01

Close Date: 2021-09-01

Grant: Close

Mechanisms of resistance to 177Lu-PSMA radioligand therapy in prostate cancer

Open Date: 2018-09-01

Close Date: 2019-08-01

Grant: Close

Elucidating mechanisms of effectiveness and resistance to Prostate Specific Membrane Antigen (PSMA) targeted Radioligand Therapy (RLT) using 177Lu-PSMA617

Open Date: 2017-07-01

Close Date: 2019-07-01

Grant: Close

Synergistic targeting of PSMA expressing tumors

Open Date: 2017-02-01

Close Date: 2019-02-01

Grant: Close

Funding of PhD studies

Open Date: 2007-07-01

Close Date: 2010-09-01

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Claire Storey

Stanford University

UNITED STATES

View details

Susan Evans Axelsson

Lund University

SWEDEN

View details

Justin Ferdinandus

University Hospital Bonn

GERMANY

View details

Tibor Szarvas

HUNGARY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katharina Lueckerath

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Fibroblast Activation Protein Inhibitor Theranostics

Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response

Fibroblast activation protein positron emission tomography and histopathology in a single-center database of 324 patients and 21 tumor entities

Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities

Administration routes for SSTR- / PSMA- and FAP-directed theranostic radioligands in mice

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer

Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer.

PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates

Imaging Inflammation with Positron Emission Tomography.

Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer.

Collaborators (4)

Claire Storey

Susan Evans Axelsson

Justin Ferdinandus

Tibor Szarvas

Make your next move.